TY - JOUR
T1 - Nanotechnology solutions to restore antibiotic activity
AU - Shimanovich, U.
AU - Gedanken, A.
N1 - Publisher Copyright:
© The Royal Society of Chemistry 2016.
PY - 2016/2/7
Y1 - 2016/2/7
N2 - This review focuses on the development of nanoparticle systems that enables to enhance and restore the antibiotic activity for drug-resistant organisms. New and more aggressive antibiotic resistant bacteria and parasites calls for the development of new therapeutic strategies to overcome the inefficiency of conventional antibiotics and bypass treatment limitations related to these pathologies. Nanostructured biomaterials, nanoparticles in particular, have unique physicochemical properties such as ultra-small and controllable size, large surface area to mass ratio, high reactivity, and functionalizable structure. These properties can be applied to facilitate the administration of antimicrobial drugs, thereby overcoming some of the limitations in traditional antimicrobial therapeutics. Here the current progress and challenges in synthesizing nanoparticle platforms for restoring activity of various antimicrobial drugs are reviewed with an emphasis on antibiotics. We also call attention to the need to unite the shared interest between nanoengineers and microbiologists in developing nanotechnology for the treatment of microbial diseases.
AB - This review focuses on the development of nanoparticle systems that enables to enhance and restore the antibiotic activity for drug-resistant organisms. New and more aggressive antibiotic resistant bacteria and parasites calls for the development of new therapeutic strategies to overcome the inefficiency of conventional antibiotics and bypass treatment limitations related to these pathologies. Nanostructured biomaterials, nanoparticles in particular, have unique physicochemical properties such as ultra-small and controllable size, large surface area to mass ratio, high reactivity, and functionalizable structure. These properties can be applied to facilitate the administration of antimicrobial drugs, thereby overcoming some of the limitations in traditional antimicrobial therapeutics. Here the current progress and challenges in synthesizing nanoparticle platforms for restoring activity of various antimicrobial drugs are reviewed with an emphasis on antibiotics. We also call attention to the need to unite the shared interest between nanoengineers and microbiologists in developing nanotechnology for the treatment of microbial diseases.
UR - http://www.scopus.com/inward/record.url?scp=84961320543&partnerID=8YFLogxK
U2 - 10.1039/c5tb01527h
DO - 10.1039/c5tb01527h
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 32263154
AN - SCOPUS:84961320543
SN - 2050-7518
VL - 4
SP - 824
EP - 833
JO - Journal of Materials Chemistry B
JF - Journal of Materials Chemistry B
IS - 5
ER -